h-header

news

News dal mondo

28

Apr

Sun Pharma compra Organon

Sun Pharmaceutical Industries ha firmato un accordo definitivo per acquisire Organon & Co., spin-off di MSD focalizzato sulla salute femminile, in un’operazione interamente in contanti del valore di 11,75 miliardi di dollari. Si tratta della più grande operazione di M&A globale mai realizzata da una grande azienda farmaceutica indiana...[PharmaStar]

29

Apr

US GDUFA IV Talks Reach Tentative Agreement; America First Application Fee Waiver Added

US FDA GDUFA Reauthorization performance goals and program enhancements Riscal years 2023-2027 - Meeting...

27

Apr

US QMM: Participants scored well on commitment to quality, lower on advanced manufacturing

Pharmaceutical companies participating in the US Food and Drug Administration (FDA) Quality Maturity...

23

Apr

Top Drugs at Risk of Supply Shortages

Nearly half of 100 vulnerable medicines have at least one key starting material sourced exclusively...

23

Apr

Regulatory considerations for pharmaceutical excipient selection

The article discusses the role and importance of excipients in medicines, focusing on regulatory aspects...

slider-banner

h-footer